202 related articles for article (PubMed ID: 23720720)
21. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
[TBL] [Abstract][Full Text] [Related]
22. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.
Liu S; Yang W; Shen L; Turner JR; Coyne CB; Wang T
J Virol; 2009 Feb; 83(4):2011-4. PubMed ID: 19052094
[TBL] [Abstract][Full Text] [Related]
23. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus.
Meertens L; Bertaux C; Cukierman L; Cormier E; Lavillette D; Cosset FL; Dragic T
J Virol; 2008 Apr; 82(7):3555-60. PubMed ID: 18234789
[TBL] [Abstract][Full Text] [Related]
24. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.
Timpe JM; Stamataki Z; Jennings A; Hu K; Farquhar MJ; Harris HJ; Schwarz A; Desombere I; Roels GL; Balfe P; McKeating JA
Hepatology; 2008 Jan; 47(1):17-24. PubMed ID: 17941058
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus utilizes VLDLR as a novel entry pathway.
Ujino S; Nishitsuji H; Hishiki T; Sugiyama K; Takaku H; Shimotohno K
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):188-93. PubMed ID: 26699506
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
[TBL] [Abstract][Full Text] [Related]
28. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
J Virol; 2018 May; 92(10):. PubMed ID: 29491159
[TBL] [Abstract][Full Text] [Related]
29. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C Virus Disrupts Annexin 5-Mediated Occludin Integrity through Downregulation of Protein Kinase Cα (PKCα) and PKCη Expression, Thereby Promoting Viral Propagation.
Abe T; Marutani Y; Deng L; Matsui C; Fukasawa M; Suzuki R; Wakita T; Matsuura Y; Shoji I
J Virol; 2023 Jun; 97(6):e0065523. PubMed ID: 37272842
[TBL] [Abstract][Full Text] [Related]
31. Nuclear receptor 4 group A member 1 determines hepatitis C virus entry efficiency through the regulation of cellular receptor and apolipoprotein E expression.
Zhu W; Pei R; Jin R; Hu X; Zhou Y; Wang Y; Wu C; Lu M; Chen X
J Gen Virol; 2014 Jul; 95(Pt 7):1510-1521. PubMed ID: 24744301
[TBL] [Abstract][Full Text] [Related]
32. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
33. Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalization.
Deffieu MS; Clément CMH; Dorobantu CM; Partiot E; Bare Y; Faklaris O; Rivière B; Ayala-Nunez NV; Baumert TF; Rondé P; Mély Y; Lucansky V; Gaudin R
Hepatology; 2022 Oct; 76(4):1164-1179. PubMed ID: 35388524
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.
Jiang J; Cun W; Wu X; Shi Q; Tang H; Luo G
J Virol; 2012 Jul; 86(13):7256-67. PubMed ID: 22532692
[TBL] [Abstract][Full Text] [Related]
35. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
[TBL] [Abstract][Full Text] [Related]
36. EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry.
Potel J; Rassam P; Montpellier C; Kaestner L; Werkmeister E; Tews BA; Couturier C; Popescu CI; Baumert TF; Rubinstein E; Dubuisson J; Milhiet PE; Cocquerel L
Cell Microbiol; 2013 Jul; 15(7):1234-52. PubMed ID: 23351194
[TBL] [Abstract][Full Text] [Related]
37. Primary hepatocytes as targets for hepatitis C virus replication.
Farquhar MJ; McKeating JA
J Viral Hepat; 2008 Dec; 15(12):849-54. PubMed ID: 19087224
[TBL] [Abstract][Full Text] [Related]
38. In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface.
Davis C; Harris HJ; Hu K; Drummer HE; McKeating JA; Mullins JG; Balfe P
Cell Microbiol; 2012 Dec; 14(12):1892-903. PubMed ID: 22897233
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.
Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969
[TBL] [Abstract][Full Text] [Related]
40. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.
Westhaus S; Deest M; Nguyen ATX; Stanke F; Heckl D; Costa R; Schambach A; Manns MP; Berg T; Vondran FWR; Sarrazin C; Ciesek S; von Hahn T
J Hepatol; 2017 Aug; 67(2):237-245. PubMed ID: 28363797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
